EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Cognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: The role of age at first onset and change in depressive symptoms

Lingfeng Xue, Mariia Bocharova, Allan H Young, Dag Aarsland

Journal of Affective Disorders · 2024

DOI: 10.1016/j.jad.2024.06.003 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Lingfeng Xue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom. Electro…. Hauptthemen laut MEDLINE: Duloxetine Hydrochloride, Vortioxetine, Antidepressive Agents, Age of Onset. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Duloxetine HydrochlorideVortioxetineAntidepressive AgentsAge of OnsetCognitionHumansFemaleMaleAgedMiddle AgedTreatment OutcomePsychiatric Status Rating ScalesMajor Depressive DisorderAged, 80 and overDepressionDouble-Blind Method

Stichwörter der Autor:innen

Age at first onsetCognitive functionDuloxetineLate life depressionRandomized controlled trialVortioxetine

Substanzen

Duloxetine HydrochlorideVortioxetineAntidepressive Agents

Autor:innen und Institutionen

  • Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom. Electronic address: lingfeng.xue@kcl.ac.uk.
  • Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.
  • Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, United Kingdom.

Zitieren

APA

Xue, L., Bocharova, M., Young, A. H., & Aarsland, D. (2024). Cognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: The role of age at first onset and change in depressive symptoms. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.06.003

Vancouver

Xue L, Bocharova M, Young AH, Aarsland D. Cognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: The role of age at first onset and change in depressive symptoms. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.06.003

BibTeX
@article{Xue2024,
  author = {Xue, Lingfeng and Bocharova, Mariia and Young, Allan H and Aarsland, Dag},
  title = {Cognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: The role of age at first onset and change in depressive symptoms},
  journal = {Journal of Affective Disorders},
  year = {2024},
  doi = {10.1016/j.jad.2024.06.003}
}
Kostenlos starten →